White House withdraws controversial rule to eliminate drug rebates
Thursday, 11 July 2019 () The White House is withdrawing a controversial proposal to change how drugs are paid for, a spokesman said Thursday. The administration is scrapping a rule that would have banned “rebates,” which are essentially discounts that drug companies give to negotiators known as pharmacy benefit managers. ADVERTISEMENT This proposed rule was one of the few drug pricing moves that the pharmaceutical industry actually...
The government's decision to drop its plan to cut drug rebates from government drug plans could be a negative factor for pharma, according to AstraZeneca Biopharmaceuticals President Ruud Dobber. The..
The Trump administration has withdrawn a rule that it had said would lower drug prices by ending the system of prescription drug after-market discounts called... Reuters Also reported by •SeattlePI.com •Mondaq •Newsmax •Seattle Times